...
首页> 外文期刊>Pharmacological research: The official journal of The Italian Pharmacological Society >Tea catechins as inhibitors of receptor tyrosine kinases: mechanistic insights and human relevance.
【24h】

Tea catechins as inhibitors of receptor tyrosine kinases: mechanistic insights and human relevance.

机译:茶儿茶素作为受体酪氨酸激酶的抑制剂:机制的见解和人类相关性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Receptor tyrosine kinases (RTKs) play important roles in the control of fundamental cellular processes, influencing the balance between cell proliferation and death. RTKs have emerged as molecular targets for the treatment of various cancers. Green tea and its polyphenolic compounds, the catechins, exhibit chemopreventive and chemotherapeutic properties in many human cancer cell types, as well as in various carcinogenicity models in vivo. Epidemiological studies are somewhat less convincing, but some positive correlations have been observed. The tea catechins, including (-)-epigallocatechin-3-gallate (EGCG), have pleiotropic effects on cellular proteins and signaling pathways. This review focuses on the ability of the tea constituents to suppress RTK signaling, and summarizes the mechanisms by which EGCG and other catechins might exert their protective effects towards dysregulated RTKs in cancer cells. The findings are discussed in the context of ongoing clinical trials with RTK inhibitors, and the possibility for drugutrient interactions enhancing therapeutic efficacy.
机译:受体酪氨酸激酶(RTK)在基本细胞过程的控制中起着重要作用,影响细胞增殖与死亡之间的平衡。 RTK已成为治疗各种癌症的分子靶标。绿茶及其多酚化合物儿茶素在许多人类癌细胞类型以及各种体内致癌模型中均表现出化学预防和化学治疗特性。流行病学研究缺乏说服力,但已观察到一些正相关。茶儿茶素,包括(-)-epigallocatechin-3-gallate(EGCG),对细胞蛋白和信号通路具有多效作用。这项审查集中在茶成分抑制RTK信号的能力,并总结了EGCG和其他儿茶素可能对癌细胞中失调的RTK发挥保护作用的机制。在正在进行的RTK抑制剂临床试验的背景下讨论了这些发现,以及药物/营养物质相互作用增强治疗功效的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号